Current studies have shown that in hepatocellular carcinoma (HCC), exosomal miR-210 secreted by HCC cells can be transferred to endothelial cells, thus promoting tumor angiogenesis by targeting SMAD4 and STAT6 (Lin X. J. et al., 2018). This evidence concerns the gene STAT6 and hepatocellular carcinoma.